Musk's lawyer Alex Spiro joins Tom Brady in Chelsea stake bid
Spiro and Brady are lining up minority positions through Clearlake Capital with zero voting rights at Stamford Bridge, a template for passive sports money that wants upside without control.

Alex Spiro, the New York attorney who represents Elon Musk, is seeking to buy into Chelsea by investing in the club's majority owner, Clearlake Capital, joining former NFL quarterback Tom Brady, who is in talks over a minority shareholding at Stamford Bridge. If the deals complete, both become limited partners in Clearlake with no voting rights at Chelsea, showing how sports owners raise capital and brand power while keeping total control.
Alex Spiro, the New York attorney best known for representing Elon Musk, is seeking to buy a stake in Chelsea by investing in the club's majority owners, Clearlake Capital. The disclosure follows The Guardian's Friday report that Tom Brady, the much-decorated former NFL quarterback, is in discussions about purchasing a minority shareholding at Stamford Bridge, Chelsea's home ground. Two very different American names, one target, and a structure that tells you exactly what is really being sold here.
If both transactions complete, Brady and Spiro would become limited partners in Clearlake, with no voting rights at Chelsea. That single clause is the whole story. They are not buying control. They are not buying a board seat. They are not buying a say in who plays centre-back or who gets sacked. They are buying financial exposure to a Premier League club, wrapped inside a private equity fund, which is a very different product from owning a team. The report does not disclose the size of either stake or the price either man would pay.
Spiro arrives with a second, sharper storyline attached. He is representing Joshua Kushner, described as a planned Fifa investor, in a legal battle against Uefa. So the same lawyer who is squaring off against European football's governing body in one matter is simultaneously buying into the ecosystem that body governs. That overlap is the kind of detail that draws scrutiny in sport, where conflicts of interest are policed more by reputational risk than by any single regulator. It is not evidence of anything improper. It is, however, a reminder that the lines between adviser, investor, and counterparty in football are getting thinner every season.
The mechanic behind both names is Clearlake Capital, Chelsea's majority owner, which is seeking additional investors. When a private equity owner wants fresh capital or partial liquidity without surrendering control, it typically sells limited partner interests in the vehicle that holds the asset. Existing control stays put. New money comes in at the fund level, below the club's board, with economic rights but no governance. It is a structure that has become standard in sports over the past decade, and it is why so many star names appear on team cap tables while so few of them can actually influence a decision.
For Brady, a limited partner position offers something a straight endorsement deal never does: equity that can appreciate if the asset grows, plus the association that comes with owning a sliver of a global brand. For Spiro, an attorney who has built a practice around high-profile clients, the appeal runs along similar lines. Neither man is being handed operational power, and that is precisely why a fund is willing to take their money. Celebrity capital is cheap marketing and useful deal flow. It rarely asks for a vote.
The bigger context is the wave of American private capital into European football. Institutional investors bought into the idea that media rights, global fan bases, and matchday revenue are still under-monetised compared with US sports, where franchise values have compounded for decades. Chelsea sits inside that thesis. A fund that owns the majority of a London club can sell slices to wealthy, famous individuals who want the exposure without the headache of running anything. The club gets liquidity and star power. The fund keeps the wheel. The limited partners get the story.
What to watch from here is simple. Whether the Brady talks and the Spiro investment actually complete. Whether Clearlake lands the further investors it is seeking, and what kind of names they are. And whether this no-voting-rights limited partner model becomes the default way football clubs raise money from people who are richer in profile than in patience. If it does, expect more announcements like this one, in football and well beyond it.
For executives and boards in any capital-intensive business, the strategic read is blunt. If you control an asset people want to be associated with, you can raise money without giving up power, by selling economic participation and withholding governance. That is a lever worth pricing properly before you hand it out. The risk sits on the other side of the trade: when the same adviser appears on multiple sides of the same ecosystem, your governance, your disclosure, and your conflict policy all get tested at once. Chelsea is not the first club to run this play. It will not be the last.
This story's Key Insights and Take-aways are locked.
Create a free account to unlock Executive Actions for one credit.
Register to UnlockAlways free for Executives Club members. Join the Club
More in Business
Anthropic's record IPO lands a day before Nvidia's longest losing streak since 2008
Anthropic's record Nasdaq debut and Nvidia's longest weekly losing streak since 2008 landed within 24 hours of each other, and the contrast shows how fast the market is re-pricing the AI trade.
New World's HK$24.9B rights issue triggers 41% plunge as HK$50B debt target looms
New World Development has three levers left to erase up to HK$50 billion in borrowings by 2031, and shareholders just told the market what they think of the first one.
Chip supply chain warns new US export controls will spread beyond the target list
Suppliers, distributors and equipment makers say the latest US restrictions will not stay contained to the firms named on paper, putting orders, inventory and delivery timelines at risk across the global chip chain.



